Kerala Ayurveda Limited (BOM:530163)
India · Delayed Price · Currency is INR 220.00
+3.85 (1.78%)
At close: Mar 4, 2026
Kerala Ayurveda Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 1,277 | 1,203 | 1,032 | 934.13 | 803.54 | 620.74 |
Other Revenue | -3.7 | -3.7 | -0.22 | 2.1 | 0.91 | - |
| 1,274 | 1,200 | 1,031 | 936.23 | 804.44 | 620.74 | |
Revenue Growth (YoY) | 1.00% | 16.32% | 10.15% | 16.38% | 29.59% | -19.15% |
Cost of Revenue | 264.89 | 238.62 | 231.23 | 212.77 | 179.42 | 155.7 |
Gross Profit | 1,009 | 961.01 | 800.06 | 723.47 | 625.03 | 465.04 |
Selling, General & Admin | 795.32 | 669.63 | 391.91 | 364.26 | 282.47 | 264.57 |
Other Operating Expenses | 424.99 | 344.99 | 323.05 | 299.68 | 232.44 | 179.74 |
Operating Expenses | 1,277 | 1,064 | 736.38 | 675.01 | 526.93 | 457.09 |
Operating Income | -268.75 | -103.36 | 63.68 | 48.46 | 98.1 | 7.96 |
Interest Expense | -72.79 | -26.44 | -46.35 | -48.22 | -65.2 | -63.22 |
Interest & Investment Income | 3.35 | 3.35 | 1.64 | 0.77 | 2.55 | 0.35 |
Currency Exchange Gain (Loss) | 18.59 | 18.59 | 1.44 | -34.94 | -15.38 | -13.24 |
Other Non Operating Income (Expenses) | 97.65 | -14.49 | -13.85 | - | - | 0.78 |
EBT Excluding Unusual Items | -221.96 | -122.36 | 6.56 | -33.94 | 20.07 | -67.38 |
Other Unusual Items | - | - | - | 28.35 | 7.97 | - |
Pretax Income | -221.96 | -122.36 | 6.56 | -5.59 | 28.04 | -67.38 |
Income Tax Expense | 21.04 | 17.23 | 12.16 | -1.31 | 4.11 | -18.95 |
Earnings From Continuing Operations | -243 | -139.59 | -5.6 | -4.28 | 23.93 | -48.44 |
Minority Interest in Earnings | 7.1 | - | - | -4.73 | -0.32 | - |
Net Income | -235.91 | -139.59 | -5.6 | -9.01 | 23.61 | -48.44 |
Net Income to Common | -235.91 | -139.59 | -5.6 | -9.01 | 23.61 | -48.44 |
Shares Outstanding (Basic) | 12 | 12 | 11 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 12 | 12 | 11 | 11 | 11 | 11 |
Shares Change (YoY) | 3.90% | 10.28% | 3.35% | - | -0.41% | 0.42% |
EPS (Basic) | -19.48 | -11.60 | -0.51 | -0.85 | 2.24 | -4.57 |
EPS (Diluted) | -19.48 | -11.60 | -0.51 | -0.85 | 2.24 | -4.57 |
Free Cash Flow | - | -84.95 | -20.54 | 36.75 | -33.51 | 63.86 |
Free Cash Flow Per Share | - | -7.06 | -1.88 | 3.48 | -3.17 | 6.02 |
Gross Margin | 79.20% | 80.11% | 77.58% | 77.27% | 77.70% | 74.92% |
Operating Margin | -21.10% | -8.62% | 6.17% | 5.18% | 12.19% | 1.28% |
Profit Margin | -18.52% | -11.64% | -0.54% | -0.96% | 2.94% | -7.80% |
Free Cash Flow Margin | - | -7.08% | -1.99% | 3.93% | -4.17% | 10.29% |
EBITDA | -244.75 | -82.3 | 80.82 | 59.53 | 110.11 | 20.74 |
EBITDA Margin | -19.22% | -6.86% | 7.84% | 6.36% | 13.69% | 3.34% |
D&A For EBITDA | 24 | 21.06 | 17.14 | 11.08 | 12.02 | 12.78 |
EBIT | -268.75 | -103.36 | 63.68 | 48.46 | 98.1 | 7.96 |
EBIT Margin | -21.10% | -8.62% | 6.17% | 5.18% | 12.19% | 1.28% |
Effective Tax Rate | - | - | 185.41% | - | 14.66% | - |
Revenue as Reported | 1,408 | 1,222 | 1,035 | 937 | 807 | 621.86 |
Advertising Expenses | - | 91.9 | 22.81 | 43.77 | 27.31 | 17.75 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.